Treasury Yield Surge Challenges RiskFree Notion Opening Opportunities in Intermediate and HighYield Bonds Q4 Earnings Season Updates EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains Beyond Inc to Acquire Buy Buy Baby Brand Reuniting with Bed Bath Beyond Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment Summer Electric Bills Surge as Rising Temperatures and Power Costs Raise Concerns Microns 2B Virginia Expansion Marks Milestone for Advanced DRAM Production in the US CRNC Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Uptick MX Q1 2026 Earnings Strong EPS Beat Provides Some Relief as Revenue Picture Remains Opaque CIT Inc Q1 2026 Earnings EPS Misses Estimates Amid Market Caution ACN Q1 2026 Earnings Earnings Beat Expectations Amid Steady Consulting Demand Newsmax Inc NMAX Q1 2026 Earnings Narrowing Loss Beats Expectations Amid Revenue Omission Intelligent Bio Solutions Inc INBS Q1 2025 Earnings Wider Loss Than Expected Weighs on Shares Intercontinental Exchange ICE Slips 122 as Resistance Holds Near 15866 WORK Medical Technology Group WOK Slides 54 as Stock Tests Key 010 Support Level Innoviz Technologies INVZ Slides Toward Support Amid Continued Selling Pressure Fundrise Innovation Fund VCX Falls 476 Testing Key Support Levels Granite Point Mortgage Trust Inc GPMT Edges Higher Analyzing the Uptrend and Key Levels SPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Surge Littelfuse LFUS Q1 2026 Earnings EPS Beats Estimates by 1406 Shares Gain HighPeak Energy HPK Q1 2026 Earnings Large EPS Miss Sends Stock Higher A Paradoxical Market Reaction VGZ Q1 2026 Earnings Negative EPS Reflects Development Stage Stock Rises on Project Milestones Kosmos Energy KOS Q1 2026 Earnings WiderThanExpected Loss as Production Headwinds Mount SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment Tyson Foods Releases Q2 2026 Financial Results Market Eyes Protein Sector Trends Markel Group Inc MKL Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Results Weigh PTC Therapeutics PTCT Slips 140 as Biotech Sector Faces Selling Pressure